Adrian Lee is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm's antitrust and competition practice. His work encompasses a variety of civil and criminal antitrust matters, including litigation, government investigations, and mergers and acquisitions. He has experience guiding clients through Second Requests in high-stakes merger reviews before the Federal Trade Commission (FTC) and the U.S. Department of Justice. Adrian was part of the team that represented BrightSpring Health Services as the approved divestiture buyer in UnitedHealth Group's $3.3 billion acquisition of Amedisys, which Global Competition Review (GCR) named its “2026 Merger Control Matter of the Year (Americas).” He was also on the Wilson Sonsini team that advised Hawaiian Airlines on its $1.9 billion acquisition by Alaska Airlines, which GCR shortlisted for the same award in 2025.
Prior to joining the firm, Adrian worked as a corporate paralegal at an international law firm and as a managing paralegal at Credit Karma, where he focused on consumer protection and regulatory compliance. He monitored state and federal enforcement actions and proposed rulemaking on consumer protection issues, reporting weekly findings and potential risks to the regulatory team. In addition, Adrian coordinated due diligence for a range of corporate and regulatory transactions, including the company's $7 billion acquisition by Intuit, and drafted stock, equity, employment, and commercial agreements.
During law school, Adrian interned in the Mergers IV Division of the Bureau of Competition at the FTC, where he gained experience with government investigations into mergers and acquisitions. He also interned for a cloud communication technology company and the NAPABA Law Foundation.
Adrian Lee is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm's antitrust and competition practice. His work encompasses a variety of civil and criminal antitrust matters, including litigation, government investigations, and mergers and acquisitions. He has experience guiding clients through Second Requests in high-stakes merger reviews before the Federal Trade Commission (FTC) and the U.S. Department of Justice. Adrian was part of the team that represented BrightSpring Health Services as the approved divestiture buyer in UnitedHealth Group's $3.3 billion acquisition of Amedisys, which Global Competition Review (GCR) named its “2026 Merger Control Matter of the Year (Americas).” He was also on the Wilson Sonsini team that advised Hawaiian Airlines on its $1.9 billion acquisition by Alaska Airlines, which GCR shortlisted for the same award in 2025.
Prior to joining the firm, Adrian worked as a corporate paralegal at an international law firm and as a managing paralegal at Credit Karma, where he focused on consumer protection and regulatory compliance. He monitored state and federal enforcement actions and proposed rulemaking on consumer protection issues, reporting weekly findings and potential risks to the regulatory team. In addition, Adrian coordinated due diligence for a range of corporate and regulatory transactions, including the company's $7 billion acquisition by Intuit, and drafted stock, equity, employment, and commercial agreements.
During law school, Adrian interned in the Mergers IV Division of the Bureau of Competition at the FTC, where he gained experience with government investigations into mergers and acquisitions. He also interned for a cloud communication technology company and the NAPABA Law Foundation.
Dean’s Fellow; Law Student Ambassador, ABA Antitrust Law Section; Co-President, GW Antitrust Law Association; President, GW APALSA; President, National Asian Pacific American Law Students Association
Dean’s Fellow; Law Student Ambassador, ABA Antitrust Law Section; Co-President, GW Antitrust Law Association; President, GW APALSA; President, National Asian Pacific American Law Students Association